SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin launched via the Runes protocol, generating buzz for its fair distribution and strong community. Discussions highlight its potential to drive utility and transaction volume on the Bitcoin network, with many touting it as a leader in the current cycle. Community members are actively promoting its unique position compared to other meme coins and speculating about potential exchange listings.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation of a potential $15 billion licensing deal with AstraZeneca, fueling optimism around its lung cancer drug ivonescimab. Community members are actively discussing the potential deal's impact and the possibility of a short squeeze, while analysts highlight the drug's potential to challenge Keytruda in the broader oncology market.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as community members highlight its potential as the 'meme face of Bitcoin'. Many view $DOG as more than just a memecoin, emphasizing its fair launch, community ownership, and listing on major crypto exchanges. The 'cult-like army' backing the coin and its potential to mirror $SHIB's success on ETH are also driving interest.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending amid community excitement around staking application launch and ongoing buy contests. The community buzzes about the coin's strong performance relative to $SOL.X and anticipates further burns as watcher numbers climb. Enthusiastic community members highlight the project's doxxed developers and active engagement.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to positive news regarding a land sale, potentially boosting its NAV, which has captured the attention of investors looking for undervalued assets. Community discussions revolve around its low float and the possibility of a significant price surge, with some comparing it to other recent low-float runners. The stock's historical volatility and upcoming shareholder meeting add to the speculative interest.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as community members discuss its potential for integrating with real-world assets (RWA) and its possible integration with XRP. Recent price dips are being viewed as buying opportunities, with many expressing excitement about the project's future and accessibility through Phantom Wallet. The conversation highlights early-stage excitement and speculation about significant future gains.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending as investors digest the latest earnings report and guidance, with community members actively discussing the company's market position and future growth prospects. While some express disappointment, others point to positive aspects of the report and reiterate long-term bullish sentiment, viewing any price drops as buying opportunities. Technical analysis and analyst ratings are also contributing to the ongoing conversation around $CHWY.

CLV is a one-stop infrastructure platform for cross-chain and decentralized applications. The CLV chain is a Substrate-based specialized Layer-1 chain that is EVM compatible, cross-chain interoperable, and also functions as a Parachain in the Polkadot ecosystem. CLV wallet is a cross-chain all-in-one wallet, for Day-to-Day, DeFi, Metaverse and Gaming purposes. With multi-dimensional products lineup, including CLV Multi-Chain Wallets, CLV dApp Interaction Protocol, CLV Chain EVM and Universal Cross-Chain Support, CLV uniquely positioned itself as “Passport to the Omniverse.”

Clover 

Clover (CLV.X) is trending as the community anticipates a potential breakout, fueled by observations of consolidation patterns and historical cycles. Many believe a pump is imminent, drawing comparisons to previous rallies and highlighting the token's 'primed' state. However, some traders caution about potential scams and pump-and-dump schemes.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT.X) is trending as the community discusses its potential role in connecting blockchains and traditional finance, especially with developments around programmable payments and real-world asset tokenization. There's anticipation for staking options and Bring Your Own Node (BYON) which could generate passive income. However, some traders express frustration with its price action compared to other cryptocurrencies, while long-term holders remain confident in its underlying technology and future utility.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLA is trending amid discussions about its gene therapy pipeline and recent safety data from a Phase 3 trial; the community is weighing the long-term potential against short-term risks. Some traders are focusing on analyst ratings and potential for a sector rotation, while others discuss potential acquisition scenarios and ARK Invest's position in the stock. Overall, the conversation revolves around the balance between gene editing's promise and the volatility of clinical trials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hyster-Yale (HY) Reports Q2 Loss, Tops Revenue Estimates

Hyster-Yale (HY) delivered earnings and revenue surprises of -153.85% and +2.10%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Hyster-Yale (HY) Suffers a Larger Drop Than the General Market: Key Insights

The latest trading day saw Hyster-Yale (HY) settling at $42.34, representing a -2.6% change from its previous close.

Hyster-Yale (HY) Beats Stock Market Upswing: What Investors Need to Know

Hyster-Yale (HY) reached $43.77 at the closing of the latest trading day, reflecting a +2.84% change compared to its last close.

Zacks Industry Outlook Highlights Caterpillar, Komatsu, Terex and Hyster-Yale

CAT, KMTUY, TEX, and HY are gaining from infrastructure demand, mining growth, and tech-driven productivity gains.

4 Stocks to Watch in the Promising Construction & Mining Equipment Industry

The prospects of the Zacks Manufacturing - Construction and Mining industry look good. Stocks like CAT, KMTUY, TEX and HY are stocks worth a look. 

Hyster-Yale (HY) Stock Sinks As Market Gains: What You Should Know

In the most recent trading session, Hyster-Yale (HY) closed at $41.95, indicating a -1.06% shift from the previous trading day.

Hyster-Yale (HY) Laps the Stock Market: Here's Why

Hyster-Yale (HY) concluded the recent trading session at $42.27, signifying a +2.2% move from its prior day's close.

Hyster-Yale (HY) closed at $40.12 in the latest trading session, marking a +2.48% move from the prior day.

Hyster-Yale (HY) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Hyster-Yale (HY) stood at $39.52, denoting a +2.33% move from the preceding trading day.

Why Hyster-Yale (HY) Dipped More Than Broader Market Today

Hyster-Yale, Inc. engages in the manufacture of lift trucks. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), and Japan and Asia Pasific (JAPIC), Bolzoni, and Nuvera. The Americas include the United States, Canada, Mexico, Brazil, Latin America, and the corporate headquarters. The JAPIC segment involves the operations in the Asia and Pacific regions, China, and the equity earnings. The Bolzoni segment focuses on the distribution and production of attachments, forks, and lift tables marketed under the Bolzoni, Auramo, and Meyer brand names. The Nuvera segment consists of design, manufacture, and sale of hydrogen fuel cell stacks and engines. The company was founded in 1999 and is headquartered in Cleveland, OH.

Current Price	$37.70
Prev Close	$37.12
Open	$37.19
Dividend Yield	2.70%
50-Day Moving Average	$39.87
Beta	1.17
Avg. Volume	81,777.48
PE Ratio	30.26

52-Week High	$69.28
52-Week Low	$34.13
Market Capitalization	$668.11M
EPS (Annual)	$8.04
Price to Book	1.23
Revenue Per Employee	$506,847.06
Enterprise Value/EBITDA	N/A

HY
Hyster-Yale Materials Handling Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HY News

HY Hyster-Yale Materials Handling Inc - Ordinary Shares - Class A